ABVACC, INC.

Enabling next generation vaccines and immunotherapeutics by rational design

ROCKVILLE, United States · Founded 2021 · $597K raised

Employees
11–50
Founded
2021
Business Model
B2B
Website
abvacc.com
Total Funding
$597K
Last Round
$597K GrantFeb 2024

About

AbVacc is a biotechnology company focused on structure-guided design of novel vaccines and therapeutics for emerging infectious diseases, including bacterial infections (S. aureus) and viral threats (Ebola, Marburg, Nipah). The company's pipeline includes IBT-V02, a vaccine for prevention of recurrent staphylococcal skin infections, as well as potently neutralizing antibody therapeutics. AbVacc collaborates with NIAID/NIH, the National Cancer Institute, USAMRIID, and the Department of Defense.

Summary

ABVACC, INC. is a Biotech company based in ROCKVILLE, United States, founded in 2021. It has raised $597K in total, most recently a $597K Grant round in Feb 2024.

Tech & App Stack

2 technologies & apps tracked

Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.

Funding History

No funding data available yet.

Know something? Help us improve our data.

Similar Companies